cas 202062-80-4|| where to buy 4-(1,3-dioxolan-2-yl)piperidine

Nom du produit:4-(1,3-dioxolan-2-yl)piperidine

IUPAC Name:4-(1,3-dioxolan-2-yl)piperidine

Unité d'emballage	Stock disponible	Prix($)
CM743777-1g	in stock	Ʀũ
CM743777-5g	in stock	ũǜư
CM743777-10g	in stock	ƦǶȺ

Pour une utilisation en R&D uniquement..

Formulaire de demande

Nom chimique

Numéro CAS

Quantité*

Spécifications requises*
(% d'analyse, qualité du matériau, etc.)

Nom du contact*

Email du contact*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 202062-80-4 regularly via the above email.

Notes supplémentaires

Verification code*

refresh

: N° CAS:202062-80-4; Formule moléculaire:C8H15NO2; Point de fusion:-; Code SMILES:C1COC(O1)C1CCNCC1; Densité:

: Numéro de catalogue:CM743777; Poids moléculaire:157.21; Point d'ébullition:; N° Mdl:MFCD16547635; Stockage:

: Piperidines; Piperidine is an azacycloalkane that is cyclohexane in which one of the carbons is replaced by a nitrogen. Although piperidine is a common organic compound, it is an immensely important class of compounds medicinally: the piperidine ring is the most common heterocyclic subunit among FDA approved drugs.; Piperidine,Piperidine Price; if you want to know the latest news about piperidine and piperidine price, please come to our website and get a quote for free.

: Dioxolanes; Dioxolane is a heterocyclic acetal with the formula (CH2)2O2CH2. It is related to tetrahydrofuran by exchanging an oxygen for the CH2 group. The isomer 1,2-dioxolane (in which the two oxygen centers are adjacent) is a peroxide. 1,3-Dioxolane is used as solvent and comonomer in polyacetal. The dioxolane-type and their hydrogenolysis can provide very valuable partially protected building blocks either for oligosaccharide syntheses or sugar transformations.

: NX-5948; Nurix announced the presentation of the first findings of clinical responses in the brain for NX-5948. NX-5948 is an investigational, orally bioavailable, brain penetrant, small molecule degrader of BTK. NX-5948 is currently being evaluated in a Phase 1 clinical trial in patients with relapsed or refractory B cell malignancies.